Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
| Autor: | Polychronis Kemos, Sampath De Silva, Wenhao Li, William Alazawi, Jibran Mecci, Graham R. Foster, Roger Feakins, Joanne Chin-Aleong, James Hallimond Brindley, Salma Samsuddin, Wing-Kin Syn |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Aspartate transaminase Gastroenterology 03 medical and health sciences 0302 clinical medicine Diabetes mellitus Internal medicine medicine Blood test nonalcoholic steatohepatitis liver biopsy fatty liver Hepatology medicine.diagnostic_test biology business.industry Fatty liver fibrosis medicine.disease Liver 030220 oncology & carcinogenesis Liver biopsy Relative risk biology.protein 030211 gastroenterology & hepatology Metabolic syndrome business Transient elastography |
| Zdroj: | Frontline Gastroenterology |
| ISSN: | 2041-4137 |
| Popis: | ObjectiveLiver biopsy is the most accurate method for determining stage and grade of injury in non-alcoholic fatty liver disease (NAFLD). Given risks and limitations of biopsy, non-invasive tests such as NAFLD fibrosis score, aspartate transaminase (AST) to platelet ratio index, Fib-4, AST/alanine transaminase ratio and BARD are used. Prevalence and severity of NAFLD and metabolic syndrome vary by ethnicity, yet tests have been developed in largely white populations. We tested our hypothesis that non-invasive tests that include metabolic parameters are less accurate in South Asian compared with white patients.DesignRetrospective cross-sectional.SettingSpecialist liver centre.PatientsPatients with histologically confirmed NAFLD.InterventionsScores calculated using clinical data taken within 1 week and compared with histology (Kleiner).Main outcome measuresDiagnostic test characteristics.Results175 patients were identified. South Asians (n=90) were younger, had lower body mass index and lower proportion of obesity compared with white patients (n=79), with comparable rates of diabetes and liver injury. Tests are less sensitive at detecting advanced fibrosis in South Asian compared with white patients. Relative risk of correct diagnosis in white patients compared with South Asians is 1.86 (95% CI 1.4 to 2.6). In binary logistic regression models, ethnicity and platelet count predicted accuracy. Transient elastography was equally and highly accurate in both ethnicities.ConclusionsBlood test-based non-invasive scores are less accurate in South Asian patients, irrespective of metabolic parameters. Ethnicity should be considered when devising risk-stratification algorithms for NAFLD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|